The startup develops portable monitoring devices that utilize light irradiation at specific wavelengths to non-invasively measure blood glucose levels through the skin. This technology enables diabetic patients to monitor their glucose levels without the discomfort associated with traditional invasive methods.
Funding
$2.1M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Traditional blood glucose monitoring requires frequent finger pricking, causing pain and inconvenience for diabetic patients. Current methods also rely on consumable test strips, adding to the ongoing cost and burden of diabetes management.
Solution
GlucoActive offers a non-invasive glucose monitoring solution using light irradiation at specific wavelengths to measure blood glucose levels through the skin. The GlucoStation device eliminates the need for painful finger pricks and provides instant readings, offering a more convenient and comfortable way for individuals to monitor their glucose levels at home. The device adheres to stringent ISO/FDA standards for accuracy, ensuring reliable results. Unlike traditional glucometers, GlucoStation does not require any exchangeable elements like sensors or strips, representing a one-time purchase for long-term use. Future iterations of the device aim to track other blood parameters such as cholesterol, hemoglobin, and hydration.
Target Audience
The primary target audience includes individuals with diabetes seeking a pain-free and convenient method for regular glucose monitoring, as well as healthcare providers looking for innovative solutions to improve diabetes management.
Features
- Non-invasive glucose measurement using light irradiation technology
- High accuracy compliant with ISO/FDA standards
- Instant glucose readings available on demand
- No need for test strips or sensors, reducing ongoing costs
- Suitable for home use and self-monitoring
- Future capability to measure additional blood parameters (cholesterol, hemoglobin, hydration)